| Detected | Trial | Change |
|---|---|---|
| 2026-08-14 | NCT06804551 Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Chronic Low Back Pain |
overall status: Enrolling by Invitation → Active, Not Recruiting |
| 2026-08-14 | NCT06804551 Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Chronic Low Back Pain |
date change Primary completion pushed: 2026-05 -> 2027-07 |
| 2026-08-14 | NCT06804551 Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Chronic Low Back Pain |
date change Completion pushed: 2026-05 -> 2027-07 |
| 2026-08-14 | NCT06668259 Intensive Longitudinal Assessment of Stress and Stress-related Concepts Across a… |
Enrollment closed, study ongoing |
| 2026-08-13 | NCT06877572 Weight Loss Management in Endometrial Cancer Survivors |
Enrollment closed, study ongoing |
| 2026-08-08 | NCT07422987 GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women |
Enrollment closed, study ongoing |
| 2026-08-08 | NCT03969927 User-friendliness of a Portable Driving Simulator |
Trial completed |
| 2026-08-08 | NCT03969927 User-friendliness of a Portable Driving Simulator |
Enrollment reduced: 30 -> 21 participants |
| 2026-08-04 | NCT07425769 Adapting RDAD for DS |
date change Primary completion pushed: 2026-07-31 -> 2026-12-31 |
| 2026-08-04 | NCT07425769 Adapting RDAD for DS |
date change Completion pushed: 2026-07-31 -> 2026-12-31 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-04 | NCT07743567 Gestational Response, Outcomes, and Weight After GLP-1 Use | Recruiting | |
| 2026-08-04 | NCT07743632 Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06379724 | Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft | Burns | Recruiting |
| NCT06478186 | Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II Diabetes | Osteoarthritis, Knee | Recruiting |
| Phase 3 | |||
| NCT05703672 | Switching to E-cigarettes in Smokers Not Interested in Quitting | Smoking Reduction | Recruiting |
| NCT05732272 | Improving Smoking Abstinence Outcomes in the African American Community Through Extended… | Smoking Cessation | Recruiting |
| NCT07174453 | Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of… | Solid Tumor Malignancies | Recruiting |
| NCT04789070 | Phase III Trial of Sirolimus in IBM | Inclusion Body Myositis | Active, Not Recruiting |
| Phase 2 | |||
| NCT04992780 | Comparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard… | Non Small Cell Lung Cancer Stage | Recruiting |
| NCT06493370 | Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective… | Bladder Cancer | Recruiting |
| NCT06364176 | Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic… | Cystic Fibrosis | Recruiting |
| NCT06434571 | Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue… | Multiple Sclerosis | Recruiting |
| NCT05869812 | Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle… | Atrophy | Recruiting |
| NCT04530383 | Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function | Cystic Fibrosis-related Diabetes | Recruiting |
| NCT07220135 | Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer | Breast Cancer | Recruiting |
| NCT06428006 | Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in… | Multiple Sclerosis | Recruiting |
| NCT03488667 | Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach… | Gastro Esophageal Junction Cancer | Active, Not Recruiting |
| NCT06129851 | Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk… | Stage IIC Prostate Cancer AJCC v8 | Not Yet Recruiting |
| NCT05638698 | Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy… | Pancreas Cancer | Active, Not Recruiting |
| NCT05915351 | Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer… | Pancreatic Ductal Adenocarcinoma | Active, Not Recruiting |
| NCT04821141 | Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens | Risk Reduction | Active, Not Recruiting |
| NCT06178588 | Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or… | Locally Advanced Cholangiocarcinoma | Active, Not Recruiting |
| NCT05645380 | Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC | Triple Negative Breast Cancer | Active, Not Recruiting |
| NCT07643584 | De-Escalation of Axillary Management in Advanced Nodal Disease | Breast Cancer | Not Yet Recruiting |
| NCT07743632 | Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC | Breast Cancer | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06736717 | Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic… | Pancreatic Cancer | Recruiting |
| NCT04715022 | Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study) | Hypertension | Recruiting |